- Report
- June 2024
- 99 Pages
Global
From €4232EUR$4,650USD£3,595GBP
- Report
- July 2024
- 155 Pages
Global
From €3288EUR$3,613USD£2,793GBP
€3868EUR$4,250USD£3,285GBP
- Report
- January 2023
- 174 Pages
North America
From €3140EUR$3,450USD£2,667GBP
- Report
- January 2023
- 178 Pages
Middle East, Africa
From €3140EUR$3,450USD£2,667GBP
- Report
- January 2023
- 192 Pages
Europe
From €3140EUR$3,450USD£2,667GBP
- Report
- January 2023
- 169 Pages
From €3140EUR$3,450USD£2,667GBP
- Report
- January 2023
- 190 Pages
Asia Pacific
From €3140EUR$3,450USD£2,667GBP
- Report
- October 2022
- 267 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Book
- September 2021
- 288 Pages
- Book
- June 2016
- 496 Pages
- Book
- September 2024
- 352 Pages
- Book
- February 2024
- 752 Pages
Global
- Book
- May 2021
- 1488 Pages
Global
- Book
- May 2021
- 1488 Pages
Global
- Book
- November 2013
- 744 Pages
- Book
- January 2011
- 1520 Pages

The Lipid Metabolism market within the context of Biotechnology is a rapidly growing field of research and development. It focuses on the study of the metabolism of lipids, which are molecules that contain fatty acids and are essential for the functioning of cells. Lipid metabolism is important for the production of energy, the synthesis of hormones, and the regulation of cell growth and development. It is also involved in the regulation of cholesterol and triglyceride levels in the body.
Biotechnology companies are increasingly investing in research and development of new technologies to improve the understanding of lipid metabolism and its role in health and disease. This includes the development of new drugs and therapies to treat diseases related to lipid metabolism, such as obesity, diabetes, and cardiovascular diseases.
Some companies in the Lipid Metabolism market include Amgen, AstraZeneca, Merck, Novartis, and Pfizer. Show Less Read more